{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T22:41:50Z","timestamp":1789598510081,"version":"build-2803163510"},"reference-count":35,"publisher":"American Medical Association (AMA)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"Importance<\/jats:title>Neonatal hypoglycemia is common, but its association with later neurodevelopment is uncertain.<\/jats:p><\/jats:sec>Objective<\/jats:title>To examine associations between neonatal hypoglycemia and neurocognitive outcomes at corrected age 2 years.<\/jats:p><\/jats:sec>Design, Setting, and Participants<\/jats:title>Exploratory cohort analysis of the Hypoglycaemia Prevention With Oral Dextrose (hPOD) randomized clinical trial was conducted. The trial recruited participants from January 9, 2015, to May 5, 2019, with follow-up between January 26, 2017, and July 31, 2021. Infants were recruited from 9 maternity hospitals in New Zealand and assessed at home or in a research clinic. Children born late preterm and at term at risk of neonatal hypoglycemia but without evidence of acute or imminent illness in the first hour after birth were screened and treated to maintain blood glucose concentrations greater than or equal to 47 mg\/dL.<\/jats:p><\/jats:sec>Exposures<\/jats:title>Hypoglycemia was defined as any blood glucose concentration less than 47 mg\/dL, recurrent as 3 or more episodes, and severe as less than 36 mg\/dL.<\/jats:p><\/jats:sec>Main Outcomes and Measures<\/jats:title>Neurologic examination and tests of development (Bayley III) and executive function. The primary outcome was neurosensory impairment (any of the following: blindness, deafness, cerebral palsy, developmental delay, or executive function total score worse than 1.5 SD below the mean).<\/jats:p><\/jats:sec>Results<\/jats:title>A total of 1197 of 1321 (91%) eligible children were assessed at a mean of corrected age 24 months; 616 (52%) were male. Compared with the normoglycemia group, children who experienced hypoglycemia were more likely to have neurosensory impairment (111 [23%] vs 125 [18%]; adjusted risk ratio [aRR], 1.28; 95% CI, 1.01-1.60), particularly if they experienced severe episodes (30 [28%] vs 125 [18%]; aRR, 1.68; 95% CI, 1.20-2.36), but not recurrent episodes (12 [19%] vs 125 [18%]; aRR, 1.06; 95% CI, 0.63-1.80). The risk of cognitive, language, or motor delay was similar between groups, but children who experienced hypoglycemia had lower Bayley-III composite cognitive (adjusted mean difference [aMD], \u22121.48; 95% CI, \u22122.79 to \u22120.18) and motor scores (aMD, \u22122.05; 95% CI, \u22123.30 to \u22120.79).<\/jats:p><\/jats:sec>Conclusions and Relevance<\/jats:title>In children born at risk of hypoglycemia but otherwise well, those who experienced neonatal hypoglycemia were more likely to have neurosensory impairment at corrected age 2 years, with higher risks after severe episodes. Further research is required to determine causality.<\/jats:p><\/jats:sec>","DOI":"10.1001\/jamanetworkopen.2022.35989","type":"journal-article","created":{"date-parts":[[2022,10,11]],"date-time":"2022-10-11T15:06:00Z","timestamp":1665500760000},"page":"e2235989","source":"Crossref","is-referenced-by-count":36,"title":["Neurocognitive Outcomes at Age 2 Years After Neonatal Hypoglycemia in a Cohort of Participants From the hPOD Randomized Trial"],"prefix":"10.1001","volume":"5","author":[{"given":"Taygen","family":"Edwards","sequence":"first","affiliation":[{"name":"Liggins Institute, The University of Auckland, Auckland, New Zealand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane M.","family":"Alsweiler","sequence":"additional","affiliation":[{"name":"Department of Paediatrics: Child and Youth Health, The University of Auckland, Auckland, New Zealand"},{"name":"Newborn Services, Auckland City Hospital, Auckland, New Zealand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Greg D.","family":"Gamble","sequence":"additional","affiliation":[{"name":"Liggins Institute, The University of Auckland, Auckland, New Zealand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Griffith","sequence":"additional","affiliation":[{"name":"Kidz First Neonatal Care, Counties Manukau Health, Auckland, New Zealand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luling","family":"Lin","sequence":"additional","affiliation":[{"name":"Liggins Institute, The University of Auckland, Auckland, New Zealand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher J. D.","family":"McKinlay","sequence":"additional","affiliation":[{"name":"Department of Paediatrics: Child and Youth Health, The University of Auckland, Auckland, New Zealand"},{"name":"Kidz First Neonatal Care, Counties Manukau Health, Auckland, New Zealand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenny A.","family":"Rogers","sequence":"additional","affiliation":[{"name":"Liggins Institute, The University of Auckland, Auckland, New Zealand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Thompson","sequence":"additional","affiliation":[{"name":"School of Optometry and Vision Science, Waterloo, Canada"},{"name":"Center for Eye and Vision Research, Hong Kong"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trecia A.","family":"Wouldes","sequence":"additional","affiliation":[{"name":"Department of Psychological Medicine, The University of Auckland, Auckland, New Zealand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane E.","family":"Harding","sequence":"additional","affiliation":[{"name":"Liggins Institute, The University of Auckland, Auckland, New Zealand"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2022,10,11]]},"reference":[{"issue":"5","key":"zoi221015r1","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1016\/j.jpeds.2009.06.044","article-title":"Knowledge gaps and research needs for understanding and treating neonatal hypoglycemia: workshop report from Eunice Kennedy Shriver National Institute of Child Health and Human Development.","volume":"155","author":"Hay","year":"2009","journal-title":"J Pediatr"},{"issue":"5","key":"zoi221015r2","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1016\/j.jpeds.2012.05.022","article-title":"Incidence of neonatal hypoglycemia in babies identified as at risk.","volume":"161","author":"Harris","year":"2012","journal-title":"J Pediatr"},{"issue":"1","key":"zoi221015r3","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1542\/peds.2007-2822","article-title":"Patterns of cerebral injury and neurodevelopmental outcomes after symptomatic neonatal hypoglycemia.","volume":"122","author":"Burns","year":"2008","journal-title":"Pediatrics"},{"issue":"4","key":"zoi221015r4","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1016\/j.jpeds.2005.11.015","article-title":"Neonatal hypoglycemia and occipital cerebral injury.","volume":"148","author":"Filan","year":"2006","journal-title":"J Pediatr"},{"issue":"6","key":"zoi221015r5","doi-asserted-by":"publisher","first-page":"2231","DOI":"10.1542\/peds.2005-1919","article-title":"Neurodevelopment after neonatal hypoglycemia: a systematic review and design of an optimal future study.","volume":"117","author":"Boluyt","year":"2006","journal-title":"Pediatrics"},{"issue":"2","key":"zoi221015r6","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1159\/000492859","article-title":"Neonatal glycaemia and neurodevelopmental outcomes: a systematic review and meta-analysis.","volume":"115","author":"Shah","year":"2019","journal-title":"Neonatology"},{"issue":"10","key":"zoi221015r7","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1001\/jamapediatrics.2017.1579","article-title":"Association of neonatal glycemia with neurodevelopmental outcomes at 4.5 years.","volume":"171","author":"McKinlay","year":"2017","journal-title":"JAMA Pediatr"},{"issue":"1","key":"zoi221015r8","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1186\/s12887-019-1509-4","article-title":"Follow-up study of neurodevelopment in 2-year-old infants who had suffered from neonatal hypoglycemia.","volume":"19","author":"Qiao","year":"2019","journal-title":"BMC Pediatr"},{"issue":"12","key":"zoi221015r9","doi-asserted-by":"publisher","first-page":"1981","DOI":"10.1007\/s00431-020-03729-x","article-title":"Neurodevelopmental outcomes after moderate to severe neonatal hypoglycemia.","volume":"179","author":"Rasmussen","year":"2020","journal-title":"Eur J Pediatr"},{"issue":"120","key":"zoi221015r10","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1186\/s12887-015-0440-6","article-title":"Randomised trial of neonatal Hypoglycaemia Prevention With Oral Dextrose Gel (hPOD): study protocol.","volume":"15","author":"Harding","year":"2015","journal-title":"BMC Pediatr"},{"issue":"1","key":"zoi221015r11","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1003411","article-title":"Evaluation of oral dextrose gel for prevention of neonatal hypoglycemia (hPOD): a multicenter, double-blind randomized controlled trial.","volume":"18","author":"Harding","year":"2021","journal-title":"PLoS Med"},{"issue":"12","key":"zoi221015r12","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1001\/jama.2022.2363","article-title":"Prophylactic oral dextrose gel and neurosensory impairment at 2-year follow-up of participants in the hPOD randomized trial.","volume":"327","author":"Edwards","year":"2022","journal-title":"JAMA"},{"issue":"5","key":"zoi221015r13","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1111\/jpc.v58.5","article-title":"Variations in New Zealand and Australian guidelines for the management of neonatal hypoglycaemia: a secondary analysis from the Hypoglycaemia Prevention With Oral Dextrose Gel trial (hPOD).","volume":"58","author":"Rajay","year":"2022","journal-title":"J Paediatr Child Health"},{"issue":"11","key":"zoi221015r15","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0188158","article-title":"Executive function assessment in New Zealand 2-year olds born at risk of neonatal hypoglycemia.","volume":"12","author":"Ansell","year":"2017","journal-title":"PLoS One"},{"issue":"10","key":"zoi221015r18","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1007\/s10654-018-0425-5","article-title":"Moderate neonatal hypoglycemia and adverse neurological development at 2-6 years of age.","volume":"33","author":"Wickstr\u00f6m","year":"2018","journal-title":"Eur J Epidemiol"},{"issue":"10","key":"zoi221015r19","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1001\/jamapediatrics.2015.1631","article-title":"Association between transient newborn hypoglycemia and fourth-grade achievement test proficiency: a population-based study.","volume":"169","author":"Kaiser","year":"2015","journal-title":"JAMA Pediatr"},{"issue":"16","key":"zoi221015r20","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1056\/NEJMoa1504909","article-title":"Neonatal glycemia and neurodevelopmental outcomes at 2 years.","volume":"373","author":"McKinlay","year":"2015","journal-title":"N Engl J Med"},{"issue":"1","key":"zoi221015r21","doi-asserted-by":"publisher","first-page":"8132","DOI":"10.1038\/s41598-019-44609-1","article-title":"Factors influencing glycaemic stability after neonatal hypoglycaemia and relationship to neurodevelopmental outcome.","volume":"9","author":"Burakevych","year":"2019","journal-title":"Sci Rep"},{"issue":"6","key":"zoi221015r22","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1056\/NEJMoa1905593","article-title":"Lower versus traditional treatment threshold for neonatal hypoglycemia.","volume":"382","author":"van Kempen","year":"2020","journal-title":"N Engl J Med"},{"issue":"3","key":"zoi221015r23","doi-asserted-by":"publisher","first-page":"e622","DOI":"10.1542\/peds.2009-3598","article-title":"Late preterm infants have worse 24-month neurodevelopmental outcomes than term infants.","volume":"127","author":"Woythaler","year":"2011","journal-title":"Pediatrics"},{"issue":"58","key":"zoi221015r24","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/1471-2431-14-58","article-title":"Associations between preterm birth, small-for-gestational age, and neonatal morbidity and cognitive function among school-age children in Nepal.","volume":"14","author":"Christian","year":"2014","journal-title":"BMC Pediatr"},{"key":"zoi221015r25","doi-asserted-by":"publisher","first-page":"121","DOI":"10.2337\/diab.40.2.S121","article-title":"Long-term prospective evaluation of offspring of diabetic mothers.","volume":"40","author":"Silverman","year":"1991","journal-title":"Diabetes"},{"issue":"3","key":"zoi221015r26","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1136\/archdischild-2020-320305","article-title":"Two-year outcomes after dextrose gel prophylaxis for neonatal hypoglycaemia.","volume":"106","author":"Griffith","year":"2021","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"issue":"12","key":"zoi221015r27","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1001\/jama.2022.0992","article-title":"Association of neonatal hypoglycemia with academic performance in mid-childhood.","volume":"327","author":"Shah","year":"2022","journal-title":"JAMA"},{"issue":"4","key":"zoi221015r28","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1016\/S0022-3476(99)70209-X","article-title":"Long-term effects of neonatal hypoglycemia on brain growth and psychomotor development in small-for-gestational-age preterm infants.","volume":"134","author":"Duvanel","year":"1999","journal-title":"J Pediatr"},{"issue":"6659","key":"zoi221015r29","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1136\/bmj.297.6659.1304","article-title":"Adverse neurodevelopmental outcome of moderate neonatal hypoglycaemia.","volume":"297","author":"Lucas","year":"1988","journal-title":"BMJ"},{"issue":"105122","key":"zoi221015r30","doi-asserted-by":"publisher","DOI":"10.1016\/j.earlhumdev.2020.105122","article-title":"Relationships between intelligence, executive function and academic achievement in children born very preterm.","volume":"148","author":"Dai","year":"2020","journal-title":"Early Hum Dev"},{"key":"zoi221015r31","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.jpeds.2021.03.057","article-title":"Effect of prophylactic dextrose gel on continuous measures of neonatal glycemia: secondary analysis of the pre-hPOD trial.","volume":"235","author":"Hegarty","year":"2021","journal-title":"J Pediatr"},{"issue":"1","key":"zoi221015r32","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0116255","article-title":"Real-time continuous glucose monitoring reduces the duration of hypoglycemia episodes: a randomized trial in very low birth weight neonates.","volume":"10","author":"Uettwiller","year":"2015","journal-title":"PLoS One"},{"issue":"2","key":"zoi221015r33","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1111\/dmcn.13232","article-title":"Bayley-III motor scale and neurological examination at 2 years do not predict motor skills at 4.5 years.","volume":"59","author":"Burakevych","year":"2017","journal-title":"Dev Med Child Neurol"},{"issue":"5","key":"zoi221015r34","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1111\/dmcn.12049","article-title":"Does the Bayley-III Motor Scale at 2 years predict motor outcome at 4 years in very preterm children?","volume":"55","author":"Spittle","year":"2013","journal-title":"Dev Med Child Neurol"},{"issue":"5","key":"zoi221015r35","doi-asserted-by":"publisher","first-page":"e1258","DOI":"10.1542\/peds.2014-3039","article-title":"Bayley-III cognitive and language scales in preterm children.","volume":"135","author":"Spencer-Smith","year":"2015","journal-title":"Pediatrics"},{"key":"zoi221015r14","volume-title":"Bayley Scales of Infant and Toddler Development","author":"Bayley","year":"2006","edition":"3rd ed"},{"key":"zoi221015r16","volume-title":"NZDep2018 Index of Deprivation, Interim Research Report, December 2019","author":"Atkinson","year":"2019"},{"key":"zoi221015r17","unstructured":"Stats NZ. Ethnicity New Zealand Standard Classification 2005 V2.1.0. Accessed September 3, 2021. https:\/\/bit.ly\/3MkvJrZ"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2797191\/edwards_2022_oi_221015_1664551382.74407.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,11]],"date-time":"2022-10-11T15:06:05Z","timestamp":1665500765000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2797191"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,11]]},"references-count":35,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2022,10,3]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2022.35989","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,11]]}}}